P01.15 Immune-Related Adverse Effects of Immunotherapy in Patients with Advanced Non-Small Cell Lung Carcinoma

Immunotherapy is nowadays one of the most used treatments in oncology, although it is not free of adverse effects. In this study, we intended to analyse therapeutic response and immune-related adverse effects (irAEs) of immunotherapy in a sample of patients with non-small cell lung carcinoma (NSCLC) treated with pembrolizumab or nivolumab.